Conexeu Sciences Inc. (CNXU) Cash Flow Statement
Where CNXU’s cash came from and went, FY2025
October 31, 2025 · U.S. dollars- Cash from operations
- −$1.7M
- Capital expenditures
- $18,668
- Free cash flow
- −$1.7M
- Returned to shareholders
- —
- Change in cash
- $4.5M cash at year-end $4.8M
Drawn to scale: where the cash came from and how it was used. Hover for values.
CNXU operating cash flow, capex and free cash flow
CNXU cash flow trends, FY2024–FY2025
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Operating cash flow | −$225,439FY2024 | −$1.7MFY2025 | — | |
| Capital expenditures | $0FY2024 | $18,668FY2025 | — | |
| Free cash flow | −$225,439FY2024 | −$1.7MFY2025 | — | |
| Stock-based compensation | $6,807FY2024 | $1.3MFY2025 | +19,649.9%/yr |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
CNXU cash flow by activity
CNXU net income vs operating cash flow
Operating cash flow above net income usually means earnings are backed by cash (depreciation and stock-based pay are non-cash expenses).
CNXU cash flow statement
| FY2025 | FY2024 | |
|---|---|---|
| Operating activities | ||
| Net income | −$3.9M | −$471,867 |
| Depreciation & amortization | $17,250 | $0 |
| Stock-based compensation | $1.3M | $6,807 |
| Change in working capital | $97,588 | $422,571 |
| Other non-cash items | $794,368 | −$182,950 |
| Cash from operating activities | −$1.7M | −$225,439 |
| Investing activities | ||
| Capital expenditures | −$18,668 | $0 |
| Financing activities | ||
| Net borrowing (repayment) | −$94,206 | $0 |
| Shares issued | $6.4M | $531,000 |
| Other financing | −$46,367 | $3,637 |
| Cash from financing activities | $6.3M | $534,637 |
| Summary | ||
| Net change in cash | $4.5M | $309,198 |
| Cash at end of period | $4.8M | $314,616 |
| Free cash flow | −$1.7M | −$225,439 |
| Jul '26 | Apr '26 | Jan '26 | Oct '25 | Jul '25 | Apr '25 | Jan '25 | |
|---|---|---|---|---|---|---|---|
| Operating activities | |||||||
| Net income | −$7.7M | −$2.3M | −$1.7M | −$1.9M | −$1.3M | −$458,050 | −$290,064 |
| Depreciation & amortization | $5,436 | $11,420 | $6,440 | $6,646 | $6,640 | $3,401 | $563 |
| Stock-based compensation | — | — | $0 | $863,880 | — | — | $66,000 |
| Change in working capital | −$3.2M | $181,218 | −$13,447 | $150,065 | −$84,201 | $27,586 | $4,138 |
| Other non-cash items | $4.2M | $307,720 | $189,474 | $424,717 | $802,326 | −$1,689 | −$16,490 |
| Cash from operating activities | −$6.8M | −$1.8M | −$1.5M | −$431,565 | −$573,805 | −$428,752 | −$235,853 |
| Investing activities | |||||||
| Capital expenditures | −$41,400 | −$30,085 | −$4,744 | $0 | −$400 | −$4,760 | −$13,508 |
| Investments (net) | $0 | — | — | — | $0 | — | — |
| Financing activities | |||||||
| Net borrowing (repayment) | $0 | — | — | $0 | $3,911 | — | — |
| Shares issued | $0 | $1.9M | $3.0M | $4.4M | $1.5M | $0 | $550,000 |
| Other financing | $1.7M | $488,847 | $410,832 | $57,449 | −$99,626 | −$102,307 | $0 |
| Cash from financing activities | $1.7M | $2.4M | $3.4M | $4.5M | $1.4M | −$102,307 | $550,000 |
| Summary | |||||||
| Net change in cash | −$5.1M | $592,887 | $1.9M | $4.0M | $758,107 | −$535,819 | $300,639 |
| Cash at end of period | $2.2M | $7.3M | $6.7M | $4.8M | $833,128 | $79,436 | $612,273 |
| Free cash flow | −$6.8M | −$1.8M | −$1.5M | −$431,565 | −$574,205 | −$433,512 | −$249,361 |
Negative numbers are cash paid out. Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported; data from EODHD.
CNXU cash generation
In fiscal 2025 (ended October 31, 2025), Conexeu Sciences generated -$1.7 million of cash from operations and spent $0.0 million on capital expenditures, leaving free cash flow of -$1.7 million. Cash and equivalents rose by $4.5 million over the year.
Related: CNXU income statement, CNXU balance sheet. See the CNXU stock overview for the latest quote and news.
CNXU cash flow FAQ
What is Conexeu Sciences's free cash flow?
Conexeu Sciences's free cash flow was -$1.7 million in fiscal 2025: -$1.7 million of operating cash flow minus $0.0 million of capital expenditures It was -$0.2 million a year earlier..
How much cash does Conexeu Sciences generate from operations?
Conexeu Sciences generated -$1.7 million of cash from operating activities in fiscal 2025.
How much does Conexeu Sciences spend on capital expenditures?
Conexeu Sciences spent $0.0 million on capital expenditures in fiscal 2025.